Market cap
₹910 Cr
Revenue (TTM)
₹650 Cr
P/E Ratio
13.8
P/B Ratio
6.3
Div. Yield
0 %
Quality Score
2/10
Growth Score
6/10
Valuation Score
6/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹66 Cr
-
ROE
84.2 %
-
ROCE
36 %
-
Industry P/E
42.46
-
EV/EBITDA
10.4
-
Debt to Equity
1
-
Book Value
₹41.3
-
EPS
₹20.7
-
Face value
10
-
Shares outstanding
34,939,398
10 Years Aggregate
CFO
₹300.59 Cr
EBITDA
₹184.98 Cr
Net Profit
₹207.43 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Wanbury
| 15.4 | 2.1 | 5.5 | -12.2 | 66.8 | 21.0 | 20.2 |
|
BSE Healthcare
| 9.3 | 0.6 | 11.8 | 9.5 | 23.7 | 13.8 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Wanbury
| -23.5 | 127.0 | 157.2 | -41.5 | 71.1 | 150.1 | -9.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Wanbury
|
261.5 | 910.0 | 650.3 | 66.1 | 14.2 | 56.7 | 13.8 | 6.3 |
| 3,136.3 | 25,674.8 | 1,339.4 | 356.4 | 33.2 | 23.2 | 72.1 | 15.5 | |
| 413.8 | 15,838.3 | 2,268.6 | 150.1 | 10.6 | 5.4 | 88.4 | 4.0 | |
| 782.1 | 19,386.4 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 973.5 | 15,523.5 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39 | 2.2 | |
| 883.5 | 15,819.9 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.2 | 1.7 | |
| 1,651.2 | 18,922.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 160.2 | 21,328.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.6 | |
| 440.3 | 17,777.6 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.1 | 3.7 | |
| 1,989.2 | 32,323.8 | 3,373.0 | 199.0 | 12.6 | 5.9 | 151.8 | 6.5 |
Shareholding Pattern
View DetailsNews & Analysis
All News2 min read•By Research Desk
About Wanbury
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology,... rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India. Read more
-
Incorporated
1988
-
Chairman
--
-
Managing Director
--
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsOutcome Of The Board Meeting Held On 29.05.2026
29-May-2026No News & Announcements are available.
FAQs for Wanbury
What is the current share price of Wanbury Ltd Today?
The share price of Wanbury Ltd is ₹261.45 (NSE) and ₹260.45 (BSE) as of 18-Jun-2026 IST. Wanbury Ltd has given a return of 66.79% in the last 3 years.
What is the current PB & PE ratio of Wanbury Ltd?
The P/E ratio of Wanbury Ltd is 13.76 times as on 18-Jun-2026, a 68 discount to its peers’ median range of 42.46 times.
The P/B ratio of Wanbury Ltd is 6.30 times as on 18-Jun-2026, a 65 premium to its peers’ median range of 3.81 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.19
|
14.96
|
|
2024
|
8.54
|
22.63
|
|
2023
|
0.00
|
-3.53
|
|
2022
|
3.41
|
-11.25
|
|
2021
|
0.00
|
-1.33
|
What is the 52 Week High and Low of Wanbury Ltd?
The 52-week high and low of Wanbury Ltd are Rs 315.20 and Rs 161.50 as of 19-Jun-2026.
What is the market cap of Wanbury Ltd?
Wanbury Ltd has a market capitalisation of ₹ 910 Cr as on 18-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Wanbury Ltd?
Before investing in Wanbury Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
